Skip to search formSkip to main contentSkip to account menu

CEOP-IMVP-Dexa regimen

National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2009
2009
This study aimed to determine whether dose-dense therapy improves 3-year survival over the standard therapy for untreated… 
Review
1998
Review
1998
We retrospectively analyzed our chemotherapy results in patients with the Acquired Immunodeficiency Virus syndrome (AIDS) and… 
1997
1997
Primary end point of this trial was to reduce neutropenic infections during the treatment of aggressive NHL with CEOP/IMVP-Dexa… 
1996
1996
PURPOSE This trial evaluated the efficacy, toxicity, and practicability of a new intensive chemotherapy regimen in a multicenter… 
1995
1995
We report on a 28 year old Turkish woman, who was admitted to our hospital with the symptoms of malabsorption and protein-loosing… 
1991
1991
A combination of two non‐cross‐resistant regimens, CEOP and IMVP‐Dexa given every 4 weeks, three to six times according to…